​Japan diagnostic imaging market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.6% during 2025-2033. Advancements in MRI technologies, significant developments in CT scanners, and innovations in ultrasound and nuclear medicine, tailored to provide superior imaging solutions, are primarily driving the market growth.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on modality, application, and end user.

The Japan Diagnostic Imaging Equipment Market is Segmented by Product Type (X-Ray, MRI, Ultrasound, Computed Tomography, Nuclear Imaging, and Other Product Types), Application (Cardiology, Oncology, Neurology, Orthopedics, and Other Applications), and End-User (Hospitals, Diagnostic Centers, and Other End Users). The Report Offers the Value (in USD) for the Above-Mentioned Segments.

The Report Covers Japan Magnetic Resonance Imaging (MRI) Market Companies and it is segmented by Architecture (Closed MRI Systems and Open MRI Systems), Field Strength (Low Field MRI Systems, High Field MRI Systems, Very High Field MRI Systems and Ultra-high MRI Systems), Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, and Other Applications). The report offers the value (in USD million) for the above segments.

In 2020, the breast imaging market in Japan amounted to around 134 million U.S. dollars. The market was forecasted to expand by around 6.5 percent by 2026. The market can be divided into two major segments: ionizing breast imaging technologies (such as analog mammography and 3D breast tomosynthesis) and non-ionizing breast imaging technologies (such as breast ultrasound and MRI).

Recent developments include: In June 2022, Konica Minolta, Inc. released DDRAtlas Ver. 1.0, which records normal cases, as the first part of Dynamic Digital Radiography DDRAtlas on its membership website in Japan., In April 2022, Clairvo Technologies obtained market authorization for VIDA Insights, an image analysis software to assist in the reading of chest CT images developed by VIDA Diagnostics Inc. in accordance with the Pharmaceutical and Medical Device Act.. Key drivers for this market are: Increasing geriatric poulation, Increased adoption of diagnostic imaging by the medical industry; Technological advances and rapid innovation; Increased incidence of chronic diseases. Potential restraints include: Expensive procedures and equipment, Side effects of diagnostic imaging procedures. Notable trends are: Oncology Segment is expected to Account for Largest Market Share during the Forecast Period.

Snapshot img

Medical Imaging Market Size 2024-2028

The medical imaging market size is forecast to increase by USD 14.2 billion, at a CAGR of 5.95% between 2023 and 2028.

The market is witnessing significant growth due to the increasing prevalence of chronic conditions. This trend is driving the demand for advanced medical imaging technologies, including computed tomography (CT) scanners, MRI systems, and robotic medical imaging systems. The integration of artificial intelligence (AI) in medical imaging is another key trend, enabling faster and more accurate diagnoses. However, the high costs associated with these technologies and emergency medical services pose challenges to market growth. CT scanners and MRI systems are essential tools for detecting various health conditions, while robotic medical imaging systems offer improved precision and efficiency. The adoption of AI in medical imaging is revolutionizing the industry by enabling faster and more accurate diagnoses, reducing the workload on radiologists, and improving patient outcomes. Despite these advancements, the high costs of medical imaging equipment and services continue to be a major barrier to widespread adoption, particularly In the emergency medical services sector.

What will be the Size of the Medical Imaging Market During the Forecast Period?

Request Free Sample

The market encompasses a range of diagnostic tools and technologies that enable healthcare providers to visualize and analyze the interior structures of the human body. Key market drivers include the increasing demand for early disease detection and the need for faster turnaround times. New facilities and advanced imaging modalities, such as state-of-the-art CT scans, optical CT scanners, 3D MRI, and cardiovascular ultrasound systems, are increasingly being adopted to improve diagnostic accuracy and patient care.
Artificial intelligence (AI) platforms, including those developed by companies, are also gaining traction In the market due to their ability to enhance radiology operations and improve the efficiency of image analysis. The market is expected to continue growing, driven by the increasing prevalence of chronic diseases, the aging population, and advancements in imaging technology. Teaching hospitals and universities are also significant contributors to the market, as they serve as centers for innovation and research in medical imaging.

How is this Medical Imaging Industry segmented and which is the largest segment?

The medical imaging industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Hospitals
  Diagnostic imaging centers
  Clinincs/Ambulatory Care
  Research Institutions


Product

  X-ray imaging
  Ultrasound imaging
  MRI
  CT scanner imaging
  SPECT/PET imaging


Application

  Cardiology
  Oncology
  Neurology
  Orthopedics
  Gynecology/Obstetrics
  General Imaging/Radiology
  Others


Technology

  AI-Enabled Imaging
  Portable/Mobile Imaging
  Traditional/Stationary Systems


Geography

  North America

    Canada
    US
    Mexico


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period. The market is experiencing significant growth due to the increasing demand for advanced imaging techniques in hospitals and diagnostic centers. The adoption of artificial intelligence (AI) for image quantification and recognition is a key trend driving market expansion. The rising prevalence of chronic diseases, particularly among the elderly population, increases the need for medical imaging to aid in early detection and diagnosis. Technological innovations and advances in imaging modalities, such as magnetic resonance imaging (MRI), CT scanners, and X-ray imaging systems, are improving diagnostic accuracy and reliability. Increasing healthcare costs in both developed and developing countries are also fueling demand for cost-effective medical imaging solutions.

New facilities and teaching hospitals, as well as private players, are investing heavily in infrastructure and capital investments to meet this demand. The diagnostic imaging segment, including ultrasound and advanced technology, is expected to experience incremental growth during the forecast period. AI integration, teleradiology, and novel technologies are also providing growth opportunities In the market. Despite the premium price of diagnostic imaging systems, the high investment in healthcare facilities and reimbursements are expected to sustain market growth. Emerging countries are also investing in healthcare infrastructure, providing opportunities for refurbished medical

Japanese company Hitachi accounted for three percent of the world's market for diagnostic imaging in 2017. By 2024, this share is expected to decrease to 2.7 percent. Diagnostic imaging allows medical examiners to observe the inside of a body to establish a medical condition. Different techniques and machines allow radiologists and other health professionals to take a picture of the structures and activities occurring in the body. The best-known types of diagnostic imaging are radiography (X-rays), ultrasound, computed tomography (CT), and magnet resonance imaging (MRI).

The global top 3 companies

The global diagnostic imaging market is dominated by three companies which are all expected to maintain a share of about 20 or more percent until 2024. These three companies are German Siemens (Healthineers), U.S.-based General Electric Healthcare, and Philips from the Netherlands. The total global diagnostic imaging market currently is estimated at around 40 billion U.S. dollars. One of the main drivers for the market is the growing demand for early stage diagnoses of chronic diseases of an increasingly aging population, especially in developed countries.

The importance of medical imaging

Today, medical diagnosis without diagnostic imaging is hardly imaginable. It makes it possible to take a detailed image of the human body and his structures, thus allowing an exact diagnosis and to choose the most appropriate treatment. Although most types of diagnostic imaging are painless, some require a patient to remain still for an extended period inside a machine, which causes problems for some patients i.e. claustrophobia. Other methods could involve exposure to some radiation or being anesthetized. The fact that there are, for example, annually 35-40 million MRI scans in the United States alone, shows the massive impact and importance of medical imaging in today’s health care.

Snapshot img

Refurbished Medical Imaging Equipment Market Size 2024-2028

The refurbished medical imaging equipment market size is forecast to increase by USD 6.74 billion at a CAGR of 8.09% between 2023 and 2028.

The market is experiencing significant growth, driven by the increasing demand for cost-effective and efficient medical imaging solutions. This trend is particularly prominent in the US market, where healthcare providers are seeking to reduce expenses without compromising patient care. Another key factor fueling market expansion is the growing adoption of eco-friendly practices in the healthcare industry. Refurbished medical imaging equipment offers an attractive alternative to new devices, as it reduces the carbon footprint associated with manufacturing and disposal. The preference for advanced digital X-ray systems is on the rise due to their superior image quality and versatility. However, the market also faces challenges, including the negative perception of end-users towards refurbished equipment. Some stakeholders harbor concerns about the reliability and quality of refurbished devices, which can hinder market penetration. To overcome this hurdle, market participants must focus on enhancing the transparency of their refurbishment processes and providing strong warranties and support services. By addressing these challenges and capitalizing on the market's growth drivers, companies can effectively capitalize on the opportunities presented by the market.

What will be the Size of the Market during the forecast period?

Request Free Sample

The market encompasses the sale and maintenance of pre-owned diagnostic tools, primarily in the healthcare sector. With the global burden of chronic diseases on the rise, the demand for cost-effective medical imaging solutions has increased. Refurbishment offers tax benefits for healthcare providers, enabling them to acquire advanced technology while adhering to capital budget constraints. Diagnostic players, IVD and laboratories, surgical and therapeutic facilities, and patient monitoring units increasingly turn to refurbished equipment for cardiology, ecofriendly practices, and chronic condition management.
Outsourcing contracts for maintenance and warranty services further boosts market growth. Regulatory standards ensure quality assurance, while emerging economies' increasing focus on sustainability fuels adoption rates. Despite budget constraints, the market's size and direction remain strong, with medical imaging continuing to play a crucial role in disease diagnosis and treatment.

How is this Refurbished Medical Imaging Equipment Industry segmented?

The refurbished medical imaging equipment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  X-ray imaging
  Ultrasound systems
  MRI
  CT scanner imaging
  SPECT/ PET scanners


End-user

  Hospitals
  Diagnostic centers


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia
  Rest of World (ROW)

By Product Insights

The X-ray imaging segment is estimated to witness significant growth during the forecast period. X-ray imaging, a non-invasive diagnostic technique, accounts for over 50% of imaging procedures in healthcare settings. These systems are increasingly used in various clinical, scientific, and industrial applications. The demand for refurbished X-ray equipment, such as X-ray machines and C-arms, is growing due to budget constraints and the availability of tax benefits. Refurbished equipment undergoes rigorous quality assurance processes to meet regulatory standards, ensuring patient safety and diagnostic accuracy. Key chronic diseases like cardiovascular diseases and dental conditions significantly contribute to the demand for medical imaging, including X-ray systems.

Get a glance at the market report of share of various segments Request Free Sample

The X-ray imaging segment was valued at USD 2.79 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market size of various regions, Request Free Sample

The North American market for refurbished medical imaging equipment is primarily driven by the rise in chronic diseases such as cardiovascular diseases, musculoskeletal disorders, and cancer. Favorable regulatory policies and cost savings from using refurbished equipment are additional factors contributing to its growth. The US dominates this market due to the absence of restrictions on the sale, purchase, and

The Asia Pacific Diagnostics Imaging Equipment Market Report is segmented by Product (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications), End-User (Hospital, Diagnostic Centers, Others) and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The market size and forecast values are provided in terms of (USD) for all the above segments.

India Diagnostic Imaging Equipment Market Outlook 2031

The India Diagnostic Imaging Equipment Market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 10.3% during 2023–2031. The growth of the market is attributed to the increasing elderly population and rising investment in the healthcare infrastructure.



Diagnostic medical imaging is a technique that visualize physical diagnosis with help of electromagnetic radiation. This imaging equipment is used for the diagnosis of disease and to determine appropriate treatment decisions. Diagnostic imaging is useful for the clinical examination and medical implant, and the visual representation of the function of organs or tissues in the human body.

Diagnostic imaging consists of different radiological imaging equipment, such as MRI, X-ray, ultrasound, and CT scan portable systems. Multiple-use units such as digital fluoroscopy and radiography systems are also used in the hospitals and clinics.



CT scan and MRI systems are the most commonly used diagnostic imaging equipment. These equipment are used for the detection of the medical conditions by reducing the unnecessary invasive exploratory processes and to improvise patient health diagnostic imaging equipment. Diagnostic imaging also includes calculations and recording techniques to produce data that is often represented in graph form.

India Diagnostic Imaging Equipment Market Trends, Drivers, Restraints, and Opportunities

• Increasing incidence of chronic diseases, such as cancer, cardiovascular disord

Snapshot img

Japan Medical Devices Market Size 2025-2029

The medical devices market size in Japan is forecast to increase by USD 17.38 billion at a CAGR of 7.1% between 2024 and 2029.

The medical devices market is experiencing significant growth, driven by the increasing demand for minimally invasive procedures and the emergence of innovative technologies. In particular, the in-vitro diagnostics segment is gaining traction due to advancements in AI and robotics. Robotic surgical systems and surgical imaging devices are revolutionizing the healthcare industry, enabling precise and accurate diagnoses and treatments. However, challenges persist, including product recalls and limitations of medical devices. Raw materials, such as stainless steel, play a crucial role in the production of medical devices. Positron emission topography and telemedicine are also emerging trends, offering new opportunities for market expansion. As the US healthcare sector continues to evolve, staying informed about these trends and challenges is crucial for industry stakeholders.

What will be the Size of the market During the Forecast Period?

Request Free Sample

The medical devices market encompasses a diverse range of products, including medical equipment for chronic conditions management in healthcare systems and home care settings, drug delivery devices, diagnostic devices, invasive devices, and electronic medical devices. This market is driven by the increasing prevalence of cardiovascular diseases, chronic diseases, and the growing demand for minimally invasive diagnostic procedures and surgical treatments. The market's size is significant, with a substantial number of inpatient admissions and capital equipment purchases each year.
Wearable devices and electronic medical records are emerging trends, with a focus on improving patient outcomes and streamlining healthcare delivery. The market's direction is towards more personalized, minimally invasive, and cost-effective treatment options. Medical devices are integral to various diagnostic procedures, surgical procedures, and knee revision surgeries, making their role in healthcare indispensable.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product Type

  Diagnostic devices
  Therapeutic devices
  Monitoring devices
  Assistive and rehabilitation devices
  Others


Application

  Cardiovascular
  Orthopedic
  Diagnostic imaging
  Dental
  Others


End-user

  Hospitals and clinics
  Diagnostic centers
  Others


Geography

  Japan

By Product Type Insights

The diagnostic devices segment is estimated to witness significant growth during the forecast period. The diagnostic devices segment is a significant component of the market, offering advanced tools and technologies for accurate and efficient diagnosis of various medical conditions. These devices play a crucial role in healthcare, facilitating initial screenings, disease detection, and ongoing monitoring. With technological advancements, diagnostic devices continue to evolve, providing more precise and user-friendly solutions for clinical decision-making and patient care. The segment's importance will persist, fueled by the increasing demand for innovative diagnostic solutions. Non-invasive diagnostic tools will gain prominence, prioritizing patient comfort and adherence.

Chronic diseases, such as diabetes and cardiovascular conditions, will continue to drive market growth in this segment, as early and accurate diagnosis is essential for effective treatment and improved patient outcomes. Diagnostic imaging, ophthalmic diseases, and clinical diagnostic tests are among the sub-segments expected to witness substantial growth.

Get a glance at the market report of share of various segments Request Free Sample

Market Dynamics

Our Japan Medical Devices Market researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Japan Medical Devices Market?

Increasing demand for minimally invasive procedures is the key driver of the market. The Medical Device Market is experiencing significant growth due to the increasing prevalence of chronic conditions and the subsequent demand for advanced medical equipment. Chronic diseases, such as cardiovascular diseases, diabetes, and ophthalmic diseases, require ongoing patient treatment and diagnostic procedures. As a result, there is a rising demand for diagnostic devices, drug delivery devices, and invasive devices, including respiratory th

The market offers a range of products, including hardware, software, and services. Hardware components, such as AI-enabled imaging systems, are expected to account for the largest market share. Software solutions, including image analysis and reconstruction tools, are also witnessing high demand. Recent developments include: In March 2023, Butterfly Network (US) received 510 (K) clearance for an AI-enabled auto-b-line counter. This product empowers providers to assess lung conditions faster as well as earlier detect and diagnose cardiovascular diseases., In April 2021, Canon Medical Systems Corporation (Japan) expanded an AI-based image reconstruction technology in the Galan 3T MR System. This expansion assists in improving inaccessible image quality through AI. Furthermore, this system is utilize to diagnose clinical indications from the prostate to the shoulders, including all joints, the abdomen, the cardiac system, the pelvis, and the spine.. Key drivers for this market are: Rising demand for personalized medicine. Increased adoption of AI-powered diagnostic tools.. Potential restraints include: Lack of reimbursement for AI-powered imaging services. Concerns about data privacy and security.. Notable trends are: Integration of AI with other healthcare technologies, such as electronic health records (EHRs). Development of AI-based tools for image-guided therapy..

The size of the APAC Medical Imaging Devices Industry market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 7.50% during the forecast period. The market for medical imaging devices in the APAC region has been recording significant growth due to an increasing expenditure on health care, the spread of chronic diseases, and advancement in technology. As is the case with other medical imaging markets, the trend in the Asia-Pacific region is growing, where China, India, Japan, and Australia are considered leaders in adopting innovative image modalities. Indicators of growth include an increased concern for early diagnosis and preventive care, which is emerging as the demand in the market for advanced imaging modalities like MRI, CT, ultrasound, and digital X-ray systems. With the aging population rising in the region as well as lifestyle-related health issues, a greater requirement for effective diagnostic tools in the market exists. Technological advancements in the forms of artificial intelligence and machine learning are integrated into the imaging process, thereby increasing diagnosis accuracy and the efficiency of operations. Portable and point-of-care imaging devices have made it more possible to access medical imaging in remote and underserved areas. This is because market share may face challenging factors such as high-cost advanced imaging technologies and professional requirements, alongside regulatory issues. However, government initiatives may posit to help the industry growth as the health infrastructure improves and more effective medical technology is implemented. The APAC medical imaging devices industry has a great prospect for further expansion with a commitment to improving healthcare quality and patient outcomes in general. Recent developments include: October 2022: Luxonus Inc. received approval to market its photoacoustic 3D imaging system in Japan., February 2022: Siemens Healthineers and Universal Medical Imaging have signed a strategic collaboration agreement to help primary healthcare facilities in China improve the accuracy of their image screening and disease diagnosis using cutting-edge imaging diagnostic tools and remote scanning assistant equipment from Siemens Healthineers and the local medical imaging experts at Universal Medical Imaging.. Key drivers for this market are: Rising Prevalence of Chronic Diseases, Technological Advancement in Imaging Modalities; Growing Emphasis on Early Diagnosis. Potential restraints include: Lack of Skilled Radiologist, High Cost of Advanced Diagnostic Imaging Devices. Notable trends are: Oncology Segment is Expected to Witness a Healthy Growth in Coming Years.

The size of the Digital X-Ray Market in Japan market was valued at USD 560.84 Million in 2023 and is projected to reach USD 1061.32 Million by 2032, with an expected CAGR of 9.54% during the forecast period. The market growth of digital X-ray in Japan is one more symptom of this promising trend with innovative technology, increased demand for efficient diagnosis, and advanced imaging technology. Japan, in particular, boasts an impressively well-developed health care infrastructure. Innovation in medical technologies has been an important reason for increasing adoption of digital X-ray systems. These systems provide higher image quality than traditional film-based systems; they speed up the processing time as well as offer reduced radiation exposure. For this market, leading drivers are aged population demographics, which are augmenting the incidence of chronic diseases that will need to be consistently visualized, like cardiovascular diseases and cancer. The increased efforts at disease identification early at the beginning stages with preventive measures enhance the need for effective diagnostic imaging in hospitals. Advances in technology-such as in portable and wireless digital X-ray devices-are opening up wider access and usability, allowing healthcare providers to deliver timely diagnoses. AI also is used with image analysis to improve diagnostic accuracy and workflow. Some of the challenges facing this market growth include a high launch price for the digital X-ray systems, besides the need to maintain a continuum of training for the healthcare professionals. The government's initiative on quality enhancement and use of advanced imaging technologies will also help to sustain the growth better. In a nutshell, the Japanese market for digital X-rays is sure on the move to growth with concern to improve the health care situation and diagnostic in their settings. Recent developments include: April 2023: Canon Inc., Canon Medical Systems Corporation (Canon Medical), and the National Cancer Center Japan (NCC) have begun clinical research employing a next-generation X-ray CT system with photon-counting computed tomography (photon-counting CT, PCCT)., June 2022: Konica Minolta, Inc. released DDRAtlas Ver. 1.0, which records normal cases, as the first part of Dynamic Digital Radiography DDRAtlas on its membership website in Japan. With the help of a DDR system that can record dynamic images utilizing a standard X-ray system, Konica Minolta has been attempting to provide new diagnostic values in Japan.. Key drivers for this market are: Increasing Prevalence of Chronic Diseases, Increasing Technological Advancements. Potential restraints include: High Cost of Equipment. Notable trends are: Cancer Segment is Expected to Hold a Significant Market Share Over the Forecast Period.

The market size of the Asia Pacific Medical Imaging And Radiology Software Market is categorized based on Application (Type 1, Type 2, Type 3, Type 4) and Product (Type 1, Type 2, Type 3, Type 4) and Asia-Pacific region which includes China, Japan and South Korea.

[Keywords] Market include Toshiba Medical Systems Corporation (Japan), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), Neusoft Medical Systems Co. Ltd. (China)

Snapshot img

Clinical Trial Imaging Market Size 2024-2028

The clinical trial imaging market size is forecast to increase by USD 551.3 million at a CAGR of 7.5% between 2023 and 2028.

The market is experiencing significant growth due to the increasing investment in drug development for chronic diseases. Imaging techniques, such as Computed Tomography (CT), play a crucial role in clinical trials by providing valuable data for drug efficacy and safety assessments. Patient comfort is a key trend in this market, as Breast imaging technologies are being developed to minimize patient discomfort and improve the overall trial experience. Data management services are also gaining importance to ensure accurate and efficient handling of imaging data. Strict regulations, however, pose a challenge to market growth, requiring strong data security and compliance measures. Overall, the market is expected to continue its expansion, driven by the need for advanced imaging technologies to support the development of new treatments.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The integration of medical imaging technologies in clinical trials has revolutionized the biotechnology and pharmaceutical industries. By providing valuable insights into various health conditions, these advanced imaging techniques contribute significantly to the development of new therapeutics and treatments. In the realm of clinical trials, imaging technologies play a pivotal role in assessing the efficacy and safety of new drugs and therapies. Biotechnology and pharmaceutical companies increasingly rely on these technologies to gather data on disease progression, treatment response, and potential side effects. Image analysis software, fueled by artificial intelligence (AI) and machine learning algorithms, is a crucial component of this process. 



These advanced technologies enable the automated detection, measurement, and analysis of various health conditions, including oncology, non-alcoholic steatohepatitis (NASH), neurology, endocrinology, and cardiology. Virtual imaging trials, which utilize AI and machine learning, have gained considerable attention in recent years. These trials allow for remote patient monitoring and data collection, streamlining the clinical trial process and reducing costs. Imaging modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), echocardiography, nuclear medicine (positron emission tomography – PET), x-ray, ultrasound, and optical coherence tomography, are essential tools in the clinical trial landscape.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Modality

  Computed tomography
  Magnetic resonance imaging
  Ultrasound
  Positron emission tomography
  Others


End-user

  Contract research organization
  Pharmaceutical and biotechnology companies
  Research and academic institutes
  Medical device manufacturers


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia

    China
    Japan


  Rest of World (ROW)

By Modality Insights

The computed tomography segment is estimated to witness significant growth during the forecast period.

The market is experiencing notable progressions, with a notable focus on the computed tomography (CT) segment. CT imaging is a vital imaging modality in clinical trials due to its ability to generate detailed cross-sectional images of the body, which are crucial for precise diagnosis and tracking of various medical conditions, including cancer. The rising prevalence of chronic diseases and the demand for early and precise diagnosis have boosted the importance of high-resolution imaging technologies. CT scans are indispensable in evaluating disease progression and treatment effectiveness in clinical trials.

Furthermore, technological innovations in CT imaging, such as photon counting computed tomography (PCCT), are expanding the capabilities of clinical trial imaging. Magnetic Resonance Imaging (MRI), Echocardiography, Nuclear Medicine, Positron Emission Tomography (PET), and X-ray are other significant imaging modalities in clinical trials. MRI offers superior soft tissue contrast and is widely used in neurology, oncology, and cardiology trials. Hence, such factors are fuelling the growth of this segment during the forecast period.

Get a glance at the market report of share of various segments Request Free Sample

The computed tomography segment was valued at USD 317.40 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the

The APAC Magnetic Resonance Imaging Systems Industry Report is Segmented by Architecture (Closed MRI Systems and Open MRI Systems), Field Strength (Low Field MRI Systems, High Field MRI Systems, and Very High Field MRI Systems and Ultra - High MRI Systems), Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, and Other Applications), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia - Pacific). The Market Provides the Value (in USD Million) for the Above-Mentioned Segments.

Japan's Medical Devices Market is thriving, reaching a value of USD 40.29 billion, driven by various factors. The country's aging population and increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and orthopedic conditions have fueled the demand for advanced medical technologies. Additionally, rising healthcare spending and government initiatives promoting healthcare innovation further support market expansion.Japan's strong R&D ecosystem and technological advancements in imaging systems, robotics, and AI-driven diagnostics are enhancing the quality and efficiency of medical treatments. The growing adoption of wearable medical devices, minimally invasive procedures, and home healthcare solutions also contribute to market growth.The market is projected to maintain a robust CAGR of 6.75%, with increased demand for diagnostic devices, surgical instruments, and therapeutic equipment. Foreign investments and collaborations with global medical technology firms are expected to accelerate product development and accessibility in Japan’s healthcare sector.

The global market size of Medical Digital Imaging Systems is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.
Global Medical Digital Imaging Systems Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Medical Digital Imaging Systems industry. The key insights of the report:
1.The report provides key statistics on the market status of the Medical Digital Imaging Systems manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report estimates 2019-2024 market development trends of Medical Digital Imaging Systems industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report makes some important proposals for a new project of Medical Digital Imaging Systems Industry before evaluating its feasibility.
There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.
For competitor segment, the report includes global key players of Medical Digital Imaging Systems as well as some small players. At least 9 companies are included:
* GE Healthcare
* Siemens Health Care GmBH
* Koninklijk Philips N.V.
* Toshiba Medical Systems Corporation
* Hitachi Medical Corporation
* Carestream Health
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Medical Digital Imaging Systems market
* 2D (Black& White
* Color)
* 3D/4D
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Hospitals
* Clinics
* Others

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions:
* North America
* South America
* Asia & Pacific
* Europe
* MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.